Skip to main content
Clinical Trials/IRCT20190409043207N3
IRCT20190409043207N3
Completed
Phase 2

Comparison of two methods of double- trigger(GNRHa+HCG) and HCG-trigger on final oocyte maturation in normal responder patients.

Yazd University of Medical Sciences0 sites130 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Yazd University of Medical Sciences
Enrollment
130
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Yazd University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • normal responder women
  • Age less than 42 years
  • BMI \<30 Kg / m2
  • Estradiol Trigger Doses between 500 and 3000 pg / ml

Exclusion Criteria

  • Severe male factor
  • Untreated thyroid disorders
  • Severe uterine anomaly
  • Existence of pco criteria
  • FSH\> 10 days of the third menstrual cycle and AMH \<1
  • BMI less than 18 and more than 35
  • Predicting the the chance of of ovarian hyper stimulation syndrom(OHSS)
  • Hyperprolactinemia
  • Endocrine Disorders
  • Congenital adrenal hyperplasia

Outcomes

Primary Outcomes

Not specified

Similar Trials